SCHEMBL5533756

SCHEMBL5533756

C=CCOC(=Cc1ccccc1)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.39
▸ TSHR P16473 2/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ AKR1C1 Q04828 1/20 0.39
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CASP1 P29466 2/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PRMT1 Q99873 1/20 0.36
▸ CYP19A1 P11511 4/20 0.36
▸ SNCA P37840 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1526104 0.79 CYP3A4 (0.44) CYP3A4ALDH1A1TSHRHSD17B10MEN1
SCHEMBL7197167 0.78 CYP3A4 (0.49) CYP3A4ALDH1A1TSHRHSD17B10AKR1C1
SCHEMBL660284 0.78 MEN1 (0.58) ALDH1A1AKR1C1MEN1KMT2AKDM4E
SCHEMBL7158858 0.78 MEN1 (0.58) ALDH1A1AKR1C1MEN1KMT2AKDM4E
SCHEMBL1808353 0.77 AKR1C1 (0.54) CYP3A4ALDH1A1TSHRHSD17B10AKR1C1
SCHEMBL1808352 0.77 AKR1C1 (0.54) CYP3A4ALDH1A1TSHRHSD17B10AKR1C1
SCHEMBL9492865 0.76 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRHSD17B10MEN1
SCHEMBL9492868 0.76 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRHSD17B10MEN1
SCHEMBL11447957 0.76 CYP3A4 (0.46) CYP3A4ALDH1A1TSHRHSD17B10MEN1
SCHEMBL8219793 0.75 MEN1 (0.64) CYP3A4ALDH1A1TSHRHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070015840-A1 Use of an alkyl ether of hydroxystilbene for the treatment of dry skin L'OREAL (FR) 2007-01-18 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070015840-A1 Use of an alkyl ether of hydroxystilbene for the treatment of dry skin CYP8B1, HSD17B11, HSD17B1 CYP3A4 1526/4885ALDH1A1 696/4885TSHR 2043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback